Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Genentech
Company Monitoring Page for Genentech
latest headlines for company on cafepharma
Big promise is seen in 2 new breast cancer drugs
Yahoo/AP
Wed, 12/7/11 - 10:13 pm
Tags:
breast cancer
,
Genentech
,
Pertuzumab
,
Afinitor
,
Novartis
Genmab says rivals appeal U.S. ruling in patent suit
Reuters
Tue, 12/6/11 - 11:33 am
Tags:
patents
,
Genmab
,
Biogen Idec
,
Genentech
,
GSK
,
Arzerra
F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
NY Times, NY
Fri, 11/18/11 - 11:51 am
Tags:
FDA
,
Avastin
,
breast cancer
,
Roche
,
Genentech
VA Reinstates Avastin Usage For Eye Disease
Pharmalot
Thu, 11/10/11 - 01:13 pm
Tags:
Veterans Administration
,
Avastin
,
Lucentis
,
age-related macular degeneration
,
Genentech
Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha
Thu, 11/10/11 - 01:08 pm
Tags:
Curis
,
milestone payments
,
FDA
,
basal cell carcinoma
,
Genentech
,
vismodegib
Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Seeking Alpha
Sun, 10/16/11 - 07:05 pm
Tags:
Micromet
,
Pfizer
,
blinatumomab
,
acute lymphoblastic leukemia
,
leukemia
,
Bmab
,
SAR3419
,
Sanofi
,
inotuzumab
,
Genentech
,
Seattle Genetics
Doctors Grow Wary of Avastin for Eye Treatment
NY Times, NY
Wed, 10/5/11 - 10:55 am
Tags:
Genentech
,
Avastin
,
Lucentis
New label on Genentech's Avastin warns of infertility
Bizjournals.com
Wed, 10/5/11 - 10:50 am
Tags:
Avastin
,
Infertility
,
warnings
,
Genentech
Insurer Won’t Pay For Avastin Breast Cancer Use
Pharmalot
Mon, 10/3/11 - 11:03 am
Tags:
breast cancer
,
Avastin
,
insurance
,
Genentech
Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wed, 09/7/11 - 09:54 am
Tags:
Medicare
,
off-label
,
Avastin
,
Roche
,
Genentech
,
age-related macular degeneration
Off-Label Avastin Injections Linked To Blindness
Pharmalot
Wed, 08/31/11 - 09:31 am
Tags:
off-label
,
blindness
,
Avastin
,
Genentech
,
Roche
Galapagos gains third extension of Genentech deal in $35M pact
Fierce Biotech
Thu, 08/18/11 - 02:17 pm
Tags:
Genentech
,
Galapagos
,
Argenta
Array BioPharma lands Genentech drug-development deal
Bizjournals.com
Tue, 08/9/11 - 10:07 am
Tags:
drug development
,
Array Biopharma
,
Genentech
Genentech pitches Avastin compromise to FDA
Fierce Pharma
Mon, 08/8/11 - 12:39 pm
Tags:
FDA
,
breast cancer
,
Avastin
,
Genentech
PDL climbs 8% on patent case ruling
Marketwatch
Mon, 07/11/11 - 12:33 pm
Tags:
PDL Biopharma
,
patents
,
Roche
,
Genentech
,
Avastin
,
Herceptin
,
Lucentis
,
Xolair
Genentech, Once Known For Innovation, Is Pursuing A Nexium Strategy With Lucentis
Forbes
Sat, 04/30/11 - 10:07 am
Tags:
Genentech
,
Lucentis
,
macular degeneration
Roche's Genentech Sues Novartis Unit Claiming Infringement of Valcyte Drug
Bloomberg
Thu, 04/21/11 - 09:23 am
Tags:
Genentech
,
Novartis
,
Valcyte
,
generics
,
patents
,
AIDS
FDA approves Genentech vasculitis treatment
Bizjournals.com
Wed, 04/20/11 - 12:04 pm
Tags:
FDA
,
Genentech
,
vasculitis
,
Rituxan
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
Tags:
cancer
,
Carfilzomib
,
crizotinib
,
vismodegib
,
Oncovex
,
PLX4032
,
Ponatinib
,
SGN-35
,
tivozanib
,
T-DM1
,
cabozantinib
,
ONYX Pharmaceuticals
,
Pfizer
,
Genentech
,
Curis
,
Amgen
,
Plexxikon
,
Seattle Genetics
,
Ariad Pharmaceuticals
,
Aveo Pharmaceutical
,
Exelixis
,
Roche
Pfizer, Genentech and APP initiate recalls
Fierce Pharma
Mon, 03/28/11 - 11:45 am
Tags:
recalls
,
Pfizer
,
Genentech
,
APP
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.